Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10915884 | Nuclear Medicine and Biology | 2015 | 5 Pages |
Abstract
This study provides evidence of the accessibility of HAP within the breast tumor microenvironment as an in vivo imaging target for bone-seeking agents. SPECT imaging using 99mTc-MDP can be rapidly translated to the clinic. FMT imaging using Osteosense 750EX is not currently approved for clinical use and is limited to animal research.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Dayo D. Felix, John C. Gore, Thomas E. Yankeelov, Todd E. Peterson, Stephanie Barnes, Jennifer Whisenant, Jared Weis, Sepideh Shoukouhi, John Virostko, Michael Nickels, J. Oliver McIntyre, Melinda Sanders, Vandana Abramson, Mohammed N. Tantawy,